Silence Therapeutics plc (SLN)
NASDAQ: SLN · IEX Real-Time Price · USD
20.99
-0.82 (-3.76%)
At close: May 31, 2024, 4:00 PM
20.60
-0.39 (-1.86%)
After-hours: May 31, 2024, 5:33 PM EDT
Silence Therapeutics Market Cap
Silence Therapeutics has a market cap or net worth of $1.02 billion as of May 31, 2024. Its market cap has increased by 390.42% in one year.
Market Cap
1.02B
Enterprise Value
830.29M
1-Year Change
390.42%
Ranking
Category
Stock Price
$20.99
Market Cap Chart
Since September 8, 2020, Silence Therapeutics's market cap has increased from $509.40M to $1.02B, an increase of 101.12%. That is a compound annual growth rate of 20.61%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 31, 2024 | 922.70M | -3.77% |
May 30, 2024 | 958.80M | 1.26% |
May 29, 2024 | 946.90M | -2.49% |
May 28, 2024 | 971.10M | 0.82% |
May 24, 2024 | 963.20M | -0.40% |
May 23, 2024 | 967.10M | -5.25% |
May 22, 2024 | 1.02B | -2.89% |
May 21, 2024 | 1.05B | 2.40% |
May 20, 2024 | 1.03B | 1.52% |
May 17, 2024 | 1.01B | 0.27% |
May 16, 2024 | 1.01B | 14.00% |
May 15, 2024 | 884.60M | 5.62% |
May 14, 2024 | 837.50M | 1.54% |
May 13, 2024 | 824.80M | -1.83% |
May 10, 2024 | 840.20M | -7.59% |
May 9, 2024 | 909.20M | 1.55% |
May 8, 2024 | 895.30M | 1.84% |
May 7, 2024 | 879.10M | 1.33% |
May 6, 2024 | 867.60M | -0.40% |
May 3, 2024 | 871.10M | 3.24% |
May 2, 2024 | 843.80M | -0.57% |
May 1, 2024 | 848.60M | -2.01% |
Apr 30, 2024 | 866.00M | -0.09% |
Apr 29, 2024 | 866.80M | 1.27% |
Apr 26, 2024 | 855.90M | -0.07% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Calliditas Therapeutics AB (publ) | 1.07B |
Enliven Therapeutics | 1.06B |
Cassava Sciences | 1.06B |
MiMedx Group | 1.06B |
Arcturus Therapeutics Holdings | 1.05B |
Pharvaris | 1.02B |
Ironwood Pharmaceuticals | 1.00B |
Cronos Group | 989.41M |